Inventor

Jeffrey Roger Roppe

Inventor
Temecula, CA, US

Overview

29→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 29 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
A61BDiagnosis1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,730,832Aliphatic prolinamide derivatives20209,987,381Radioligands for imaging the LPA-1 receptor20189,849,109Autotaxin inhibitors and uses thereof20179,260,416'Heterocyclic autotaxin inhibitors and uses thereof'20169,000,025'Autotaxin inhibitors and uses thereof'20158,609,852'Thiazolyl mGluR5 antagonists and methods for their use'20138,541,587'Lysophosphatidic acid receptor antagonists'20138,524,748'Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors'20138,440,707'Antagonists of lysophosphatidic acid receptors'20138,399,666'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,383,654'Heterocyclic antagonists of prostaglandin D2 receptors'20138,378,107'Heteroaryl antagonists of prostaglandin D2 receptors'20138,362,044'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20138,273,780'Polycyclic antagonists of lysophosphatidic acid receptors'20128,242,143'Thiazolyl mGluR5 antagonists and methods for their use'20128,067,445'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20118,058,300'Polycyclic antagonists of lysophosphatidic acid receptors'20118,049,015'Heteroaryl antagonists of prostaglandin D2 receptors'20118,048,902'Antagonists of lysophosphatidic acid receptors'20117,977,359'5-lipdxygenase-activating protein (FLAP) inhibitors'20117,879,882'Thiazolyl mglur5 antagonists and methods for their use'20117,834,037'5-lipoxygenase-activating protein (FLAP) inhibitors'20107,592,337'Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5'20097,462,619'Pyridazine, pyrimidine and pyrazine ethyne compounds'20087,393,959'Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5'20087,365,074'Pyridazine, pyrimidine and pyrazine ethyne compounds'20087,268,151'Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5'20077,253,190'Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5'20077,105,548'Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2009Patents assigned to MERCK & CO INC (7)· patent assignee history
2006–2020Based in Temecula, CA, US· patent location history
2010–2017Patents assigned to AMIRA PHARMACEUTICALS INC (10)· patent assignee history
2011–2016Patents assigned to ROPPE JEFFREY ROGER (12)· patent assignee history
2011–2016Patents assigned to HUTCHINSON JOHN HOWARD (10)· patent assignee history
2011–2013Patents assigned to ARRUDA JEANNIE M (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ROPPE JEFFREY ROGERself122011–2016
AMIRA PHARMACEUTICALS INC102010–2017
HUTCHINSON JOHN HOWARD102011–2016
ARRUDA JEANNIE M92011–2013
MERCK & CO INC72006–2009
Locations
LocationPatentsSpan
Temecula, California, US292006–2020